Search research articles
Contact Us
Filters
Showing results (271-280 of 278) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 278 results.
British Journal of Cancer
|
February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients
M Bakker, J P Droz, A R Hanauske, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation
Ch Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2001
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres
J L Lagrange, A Ramaioli, C H Theodore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
H J Schmoll, R Souchon, S Krege, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 278) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 278 results.
British Journal of Cancer
|
February 12, 1998
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients
M Bakker, J P Droz, A R Hanauske, et al.
The Journal of Urology
|
August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers
B Escudier, J P Droz, F Rolland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation
Ch Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
J-P Lotz, B Bui, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2001
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres
J L Lagrange, A Ramaioli, C H Theodore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group
K Fizazi, S Tjulandin, R Salvioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
H J Schmoll, R Souchon, S Krege, et al.
Page
of 28